Administration de la santé publique : Questions médicales fréquentes
Nom anglais: Public Health Administration
Descriptor UI:D011635
Tree Number:N04.452.794
Termes MeSH sélectionnés :
Case-Control Studies
Questions fréquentes et termes MeSH associés
Diagnostic
2
#1
Comment évaluer l'efficacité d'un programme de santé publique ?
L'efficacité se mesure par des indicateurs de santé, des enquêtes et des analyses de données.
Évaluation des programmesSanté publique
#2
Quels outils sont utilisés pour le diagnostic en santé publique ?
Des enquêtes épidémiologiques, des statistiques de santé et des études de cohorte sont utilisés.
ÉpidémiologieStatistiques de santé
Symptômes
2
#1
Quels symptômes indiquent un problème de santé publique ?
Des épidémies, des taux de mortalité élevés et des maladies infectieuses en hausse sont des indicateurs.
ÉpidémiesMaladies infectieuses
#2
Comment les symptômes de maladies affectent-ils la santé publique ?
Ils influencent les politiques de santé, la prévention et les ressources allouées aux soins.
Politiques de santéPrévention des maladies
Prévention
2
#1
Quelles stratégies de prévention sont efficaces ?
Les campagnes de vaccination, l'éducation à la santé et les politiques de santé publique sont efficaces.
Éducation à la santéCampagnes de vaccination
#2
Comment la prévention est-elle mesurée ?
Elle est mesurée par la réduction des cas de maladies, l'augmentation des vaccinations et des dépistages.
DépistagePrévention des maladies
Traitements
2
#1
Quels traitements sont prioritaires en santé publique ?
Les vaccinations, les traitements des maladies infectieuses et la santé maternelle sont prioritaires.
VaccinationSanté maternelle
#2
Comment les traitements sont-ils administrés en santé publique ?
Ils sont souvent fournis par des programmes de santé communautaire et des campagnes de sensibilisation.
Programmes de santéSensibilisation
Complications
2
#1
Quelles complications peuvent survenir sans intervention en santé publique ?
Des épidémies, des résistances aux antibiotiques et des maladies chroniques peuvent survenir.
Résistance aux antibiotiquesMaladies chroniques
#2
Comment les complications affectent-elles les systèmes de santé ?
Elles augmentent la charge sur les systèmes de santé, nécessitant plus de ressources et de personnel.
Systèmes de santéRessources en santé
Facteurs de risque
2
#1
Quels sont les principaux facteurs de risque en santé publique ?
Les comportements à risque, la pauvreté et l'accès limité aux soins sont des facteurs clés.
Comportements à risqueAccès aux soins
#2
Comment identifier les facteurs de risque dans une population ?
Par des études épidémiologiques, des enquêtes et des analyses de données démographiques.
Analyse démographiqueÉtudes épidémiologiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Administration de la santé publique : Questions médicales les plus fréquentes",
"headline": "Administration de la santé publique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Administration de la santé publique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-23",
"dateModified": "2025-02-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Administration de la santé publique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Organisation et administration",
"url": "https://questionsmedicales.fr/mesh/D009934",
"about": {
"@type": "MedicalCondition",
"name": "Organisation et administration",
"code": {
"@type": "MedicalCode",
"code": "D009934",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N04.452"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Administration de la santé publique",
"alternateName": "Public Health Administration",
"code": {
"@type": "MedicalCode",
"code": "D011635",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Stephen Thomson",
"url": "https://questionsmedicales.fr/author/Stephen%20Thomson",
"affiliation": {
"@type": "Organization",
"name": "ANU College of Law, The Australian National University, Canberra, Australia. stephen.thomson@anu.edu.au."
}
},
{
"@type": "Person",
"name": "Muhammad Zia Ud Din",
"url": "https://questionsmedicales.fr/author/Muhammad%20Zia%20Ud%20Din",
"affiliation": {
"@type": "Organization",
"name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China."
}
},
{
"@type": "Person",
"name": "Xu Yuan Yuan",
"url": "https://questionsmedicales.fr/author/Xu%20Yuan%20Yuan",
"affiliation": {
"@type": "Organization",
"name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China. xuyuanyuanj@163.com."
}
},
{
"@type": "Person",
"name": "Naqib Ullah Khan",
"url": "https://questionsmedicales.fr/author/Naqib%20Ullah%20Khan",
"affiliation": {
"@type": "Organization",
"name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China. naqibkhan05@csu.edu.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A case-control study of infections caused by",
"datePublished": "2022-07-28",
"url": "https://questionsmedicales.fr/article/35967868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fcimb.2022.867347"
}
},
{
"@type": "ScholarlyArticle",
"name": "Errors in Surgery: A Case Control Study.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/35946794",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/SLA.0000000000005664"
}
},
{
"@type": "ScholarlyArticle",
"name": "Iron status in women with infertility and controls: a case-control study.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37361544",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1173100"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sleeve Gastrectomy in Septuagenarians: a Case-Control Study.",
"datePublished": "2022-07-05",
"url": "https://questionsmedicales.fr/article/35788952",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11695-022-06193-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diverticulitis Familiality: A Statewide Case-Control Study.",
"datePublished": "2023-07-05",
"url": "https://questionsmedicales.fr/article/37403933",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/XCS.0000000000000799"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Administration des services de santé",
"item": "https://questionsmedicales.fr/mesh/D006298"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organisation et administration",
"item": "https://questionsmedicales.fr/mesh/D009934"
},
{
"@type": "ListItem",
"position": 4,
"name": "Administration de la santé publique",
"item": "https://questionsmedicales.fr/mesh/D011635"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Administration de la santé publique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Administration de la santé publique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Administration de la santé publique",
"description": "Comment évaluer l'efficacité d'un programme de santé publique ?\nQuels outils sont utilisés pour le diagnostic en santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Case-Control+Studies#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Administration de la santé publique",
"description": "Quels symptômes indiquent un problème de santé publique ?\nComment les symptômes de maladies affectent-ils la santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Case-Control+Studies#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Administration de la santé publique",
"description": "Quelles stratégies de prévention sont efficaces ?\nComment la prévention est-elle mesurée ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Case-Control+Studies#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Administration de la santé publique",
"description": "Quels traitements sont prioritaires en santé publique ?\nComment les traitements sont-ils administrés en santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Case-Control+Studies#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Administration de la santé publique",
"description": "Quelles complications peuvent survenir sans intervention en santé publique ?\nComment les complications affectent-elles les systèmes de santé ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Case-Control+Studies#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Administration de la santé publique",
"description": "Quels sont les principaux facteurs de risque en santé publique ?\nComment identifier les facteurs de risque dans une population ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Case-Control+Studies#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un programme de santé publique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité se mesure par des indicateurs de santé, des enquêtes et des analyses de données."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic en santé publique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des enquêtes épidémiologiques, des statistiques de santé et des études de cohorte sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de santé publique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des épidémies, des taux de mortalité élevés et des maladies infectieuses en hausse sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Comment les symptômes de maladies affectent-ils la santé publique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils influencent les politiques de santé, la prévention et les ressources allouées aux soins."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de prévention sont efficaces ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les campagnes de vaccination, l'éducation à la santé et les politiques de santé publique sont efficaces."
}
},
{
"@type": "Question",
"name": "Comment la prévention est-elle mesurée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est mesurée par la réduction des cas de maladies, l'augmentation des vaccinations et des dépistages."
}
},
{
"@type": "Question",
"name": "Quels traitements sont prioritaires en santé publique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations, les traitements des maladies infectieuses et la santé maternelle sont prioritaires."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils administrés en santé publique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent fournis par des programmes de santé communautaire et des campagnes de sensibilisation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans intervention en santé publique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des épidémies, des résistances aux antibiotiques et des maladies chroniques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles les systèmes de santé ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles augmentent la charge sur les systèmes de santé, nécessitant plus de ressources et de personnel."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque en santé publique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les comportements à risque, la pauvreté et l'accès limité aux soins sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Comment identifier les facteurs de risque dans une population ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études épidémiologiques, des enquêtes et des analyses de données démographiques."
}
}
]
}
]
}
Department of Public Health, Brody School of Medicine, East Carolina University, Greenville, North Carolina (Dr Little); and North Carolina Health Care Facilities Association, Raleigh, North Carolina (Ms Welsh and Dr Sholar).
Publications dans "Administration de la santé publique" :
Infections caused by antimicrobial-resistant bacteria are a significant cause of death worldwide, and carbapenemase-producing bacteria are the principal agents. New Delhi metallo-beta-lactamase-1 prod...
A retrospective case-control study with patients hospitalized from January 2012 to February 2018 at the Hospital Civil de Guadalajara "Fray Antonio Alcalde" was designed. During this period, 139 patie...
One hundred and thirty-nine case patients with a KP-NDM-1 isolate and 486 control patients were analyzed. In the case group, acute renal failure was a significant comorbidity, hospitalization days wer...
In this study, the previous use of antibiotics, the use of a urinary catheter, the use of a central venous catheter, the use of mechanical ventilation, and ICU stay were shown to be predictors of infe...
While errors can harm patients they remain poorly studied. This study characterized errors in the care of surgical patients and examined the association of errors with morbidity and mortality....
Errors have been reported to cause <10% or >60% of adverse events. Such discordant results underscore the need for further exploration of the relationship between error and adverse events....
Patients with operations performed at a single institution and abstracted into the American College of Surgeons National Surgical Quality Improvement Program from January 1, 2018, to December 31, 2018...
Of 1899 patients, 170 were defined as cases who experienced a morbidity or mortality. The majority of cases (n=93; 55%) had at least 1 error; of the 329 matched control patients, 112 had at least 1 er...
Errors in surgical care were associated with postoperative morbidity. Reducing errors requires measurement of errors....
Iron deficiency is a common problem in subfertile women. The influence of iron status on unexplained infertility is unknown....
In a case-control study, 36 women with unexplained infertility and 36 healthy non-infertile controls were included. Parameters of iron status including serum ferritin and a serum ferritin <30 µg/dL se...
Women with unexplained infertility demonstrated a lower transferrin saturation (median 17.3%, IQR 12.7-25.2 versus 23.9%, IQR 15.4-31.6;...
Ferritin levels <30µg/L were associated with unexplained infertility and might be screened in the future. Further studies with a focus on iron deficiency and iron treatment on women with unexplained i...
There are few studies published referring to bariatric surgery in patients older than 70 years. The aim of this study is to evaluate whether there are benefits to performing sleeve gastrectomy (SG) in...
Data were retrospectively collected from a Private Clinic's electronic medical records of patients undergoing SG between June 2017 and September 2020. Inclusion criteria were patients older than 70 ye...
Fifty patients were included in the study. Both groups were similar regarding gender, weight, BMI, and presence of DM. The 30-day morbidity and mortality were similar between the groups. The patients ...
The sleeve gastrectomy surgery performed in patients over 70 years of age is safe. The early results suggest similar benefits regarding weight loss and improvement of comorbidities to those having SG ...
The etiology of diverticulitis is multifactorial and poorly understood. We estimated the familiality of diverticulitis using the Utah Population Database, a statewide database linking medical records ...
We identified patients with diverticulitis diagnosed between 1998 and 2018 and age- and sex-matched controls in the Utah Population Database. Risk of diverticulitis in family members of patients and c...
The study population included 9,563 diverticulitis patients (with 229,647 relatives) and 10,588 controls (with 265,693 relatives). Relatives of patients were more likely to develop diverticulitis (inc...
Our results indicate that the first-, second-, and third-degree relatives of diverticulitis patients are at elevated risk of developing diverticulitis. This information may aid surgeons in counseling ...
This study aimed to investigate the clinical and laboratory as well as radiological features of spondyloarthritis (SpA) patients with thrombocytosis and to explore risk factor for thrombocytosis in Sp...
A total of 145 patients with SpA were included in this study, and non-thrombocytosis was identified in 76 patients while thrombocytosis was found in 69 patients, 38 out of the 69 patients received ant...
The proportion of hip involvement (60.86% vs 36.84%, p = 0.004), bath ankylosing spondylitis disease activity index score (4.24 ± 0.55 vs 3.69 ± 0.67, p < 0.001), erythrocyte sedimentation rate (62.22...
SpA patients with thrombocytosis have a higher proportion of hip involvement and disease activity compared to non-thrombocytosis SpA patients. The potential risk factors for thrombocytosis in SPA pati...
Recent studies of the vaginal microbiome have led to a better understanding of the microbiota and interactions with the host environment, however the role of the vaginal microbiome in vestibulodynia r...
This study aims to investigate and examine differences in the bacterial and fungal microbiome among patients with vestibulodynia and healthy controls....
A case-control study was conducted examining the vaginal microbiome of 29 patients with vestibulodynia and 26 controls through Stony Brook University Obstetrics and Gynecology ambulatory clinic. Exclu...
Principal component analysis (PCA) and linear discriminant analysis effect size (LefSe) were used to identify differences in relative abundance of operational taxonomic units (OTUs) for the vaginal mi...
Lactobacillus species were dominant amongst both cases and controls. PCA of 16S and ITS OTUs did not show significant differences in microbiome composition between vestibulodynia patients and controls...
Additional studies are needed to further assess the clinical significance of these findings....
Strengths of this study include ITS amplicon sequence analysis for fungal species diversity. Limitations of this study include small sample size and lack of racial diversity....
Our study did not find significant differences in composition or diversity between the vaginal microbiomes of cases of vestibulodynia and controls; however, the data suggests differences in abundance ...
Varied reports suggest a contentious relationship of bladder malignancy with pioglitazone in patients with type 2 diabetes....
To study an association (prevalence and predictors) of bladder malignancy with pioglitazone therapy in Asian-Indian type 2 diabetes patients....
In this observational multicenter study, type 2 diabetic patients attending out-patient diabetes-clinic were evaluated. A detailed history of anti-diabetic medication, dose, duration, pioglitazone usa...
A total of 8000 patients were screened out of which 1560 were excluded. Among 6440 included patients, 1056 (16.3%) patients were in group A and 5384 (83.6%) group B. Patients on pioglitazone were olde...
Pioglitazone use in Asian-Indians is not associated with an increased bladder cancer risk. However, pioglitazone should be restricted in individuals with history of hematuria. Age more than 58 years i...
Multiple chemical sensitivity (MCS) is a chronic condition characterized by the appearance of symptoms caused by exposure to chemical compounds that are tolerable for the general population. It mainly...
Stroke is the leading cause of mortality in China. DNA methylation has essential roles in multiple diseases, but its association with stroke was barely studied. We hereby explored the association betw...
The association was discovered in a hospital-based case-control study (cases/controls = 190:190) and further validated in a prospective nested case-control study including 139 cases who developed stro...
In our study, altered HTRA1 methylation was associated with stroke at clinical and preclinical stages and thus may provide a potential biomarker in the blood for the risk evaluation and preclinical de...
